Transfer of care, Guidance
18 results
Applied filters
Acute settings and transcribing
28 January 2025Consideration needs to be given to the risk factors particularly associated with transcribing in acute settings
Transcribing in the patient's home with healthcare input
28 January 2025Consideration needs to be given to the risk factors particularly associated with transcribing in the patient's home with healthcare input
Worked example of assessing the risk of transcribing
28 January 2025Example where medicines are prescribed by both the patient’s GP and specialist clinicians, and are administered in a patient’s home.
Risk assessing transcribing for administration
28 January 2025Various factors affect the risks associated with using transcribing for medicines administration.
Understanding transcribing for medicines administration
28 January 2025Transcribing for medicines administration in healthcare requires assessment and mitigation against identified risks. These risks vary according to setting.
Semi-acute settings and transcribing
28 January 2025Consideration needs to be given to the risk factors particularly associated with transcribing in semi-acute settings
Non-acute settings with healthcare input and transcribing
28 January 2025Consideration needs to be given to the risk factors particularly associated with transcribing in non-acute settings with healthcare input
Offender healthcare settings and transcribing
28 January 2025Consideration needs to be given to the risk factors particularly associated with transcribing in offender healthcare settings
Alternatives to transcribing for medicines administration
28 January 2025Transcribing is not the preferred option for medicines administration and the alternatives should be considered before committing to transcribing.
Using Standardised Strengths of Unlicensed Liquid Medicines in Children
10 August 2023A joint statement from the Neonatal and Paediatric Pharmacy Group (NPPG) and the Royal College of Paediatrics and Child Health (RCPCH)